Key result
Preoperative anaemia is a common finding and a potentially modifiable risk factor for postoperative morbidity and mortality in patients undergoing aortic valve surgery.
This editorial highlights that preoperative anaemia is a negative prognostic factor in aortic valve surgery and suggests that its prevention and treatment may improve outcomes.
The impact of anaemia on patients undergoing aortic valve surgery is poorly understood. Anaemia is associated with aortic valve surgery. A recent article by Elmistekawy et al. [1] demonstrated that preoperative anaemia is a common finding in patients undergoing aortic valve surgery and is an important and potentially modifiable risk factor for postoperative morbidity and mortality. This analysis suggests that anaemia may serve as a negative factor in aortic valve surgery. Other studies have been carried out on this topic. Major surgery in a patient with pancytopenia might be associated with increased surgical risks, particularly for bleeding and infection. Halliday et al. [2] demonstrated that, in a logistic regression model, coexisting vascular disease, diabetes and preprocedural anaemia significantly affected the incidence of life-threatening or major bleeding. Furthermore, Kitamura et al. [3] have shown that postoperatively, a patient developed paravalvular leak and haemolytic anaemia, subsequently undergoing reoperation. Also, Van Mieghem et al. [4] found that baseline anaemia is common in patients undergoing transcatheter aortic valve implantation, forecasts a need for more red blood cell transfusions and is associated with increased 1-year mortality. Moreover, hypercoagulative states have been observed in patients with alpha-thalassaemia as beta-thalassaemia; therefore, special attention should be taken in perioperative anticoagulation therapy. Kawase et al. [5] indicated that haemolytic anaemia with aortic stenosis resolved by urgent aortic valve replacement. However, Lee and Lee [6] reported a successful cardiac surgery with extracorporeal cardiopulmonary bypass in a patient with severe aortic valve insufficiency and concomitant idiopathic aplastic anaemia. In summary, these findings suggest that anaemia may be a negative factor in aortic valve surgery. Therapeutic agents targeting anaemia might result in innovative new therapies for aortic valve surgery. Finally, we greatly enjoyed reading the article by Elmistekawy et al. and believe that the prevention and treatment of anaemia may be useful in aortic valve surgery. This project was supported by Anhui Provincial Natural Science Foundation (KJ2011A175).
No takes yet. Share an insight, caveat, or question.
Tao et al. (2013) conducted a letter in Aortic valve surgery. Preoperative anaemia was evaluated. Preoperative anaemia is a common finding and a potentially modifiable risk factor for postoperative morbidity and mortality in patients undergoing aortic valve surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: